271 related articles for article (PubMed ID: 14720406)
1. Visceral leishmaniasis treatment, Italy.
Gradoni L; Gramiccia M; Scalone A
Emerg Infect Dis; 2003 Dec; 9(12):1617-20. PubMed ID: 14720406
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
[TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Minodier P; Retornaz K; Horelt A; Garnier JM
Fundam Clin Pharmacol; 2003 Apr; 17(2):183-8. PubMed ID: 12667228
[TBL] [Abstract][Full Text] [Related]
4. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
[TBL] [Abstract][Full Text] [Related]
5. Mediterranean visceral leishmaniasis in pregnancy.
Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
[TBL] [Abstract][Full Text] [Related]
6. [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
Gradoni L; Gramiccia M; Scalone A
Parassitologia; 2004 Jun; 46(1-2):199-201. PubMed ID: 15305716
[TBL] [Abstract][Full Text] [Related]
7. [Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].
Montana M; Chochoi N; Monges P; Ravaux I; Faraut F; Gensollen S; Bongrand MC; Timon-David P; Gallais H
Pathol Biol (Paris); 2004 Mar; 52(2):66-75. PubMed ID: 15001234
[TBL] [Abstract][Full Text] [Related]
8. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR
Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
[TBL] [Abstract][Full Text] [Related]
9. [Visceral leishmaniasis in immunocompetent adult with severe sepsis].
Ezzouine H; Charra B; Benslama A; Motaouakkil S
Ann Fr Anesth Reanim; 2010 Mar; 29(3):255-6. PubMed ID: 20227234
[No Abstract] [Full Text] [Related]
10. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
Sundar S; Mehta H; Suresh AV; Singh SP; Rai M; Murray HW
Clin Infect Dis; 2004 Feb; 38(3):377-83. PubMed ID: 14727208
[TBL] [Abstract][Full Text] [Related]
12. [Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre].
di Martino L; Gramiccia M; Occorsio P; Di Muccio T; Scalone A; Gradoni L
Parassitologia; 2004 Jun; 46(1-2):221-3. PubMed ID: 15305721
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Mediterranean visceral leishmaniasis.
Gradoni L; Bryceson A; Desjeux P
Bull World Health Organ; 1995; 73(2):191-7. PubMed ID: 7743590
[TBL] [Abstract][Full Text] [Related]
14. Our experiences in visceral leishmaniasis therapy.
Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
[No Abstract] [Full Text] [Related]
15. Visceral leishmaniasis in children: a review.
Palumbo E
Minerva Pediatr; 2010 Aug; 62(4):389-95. PubMed ID: 20940672
[TBL] [Abstract][Full Text] [Related]
16. [Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations].
Aoun K; Laamrani El Idrissi A; Harrat Z; Marty P
Bull Soc Pathol Exot; 2015 Aug; 108(3):229-30. PubMed ID: 26002086
[No Abstract] [Full Text] [Related]
17. [Isolated laringeal leishmaniasis and bone marrow culture (reply)].
Benítez MD; Miranda C; Navarro JM; Morillas F; Martín J; de La Rosa M
Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):133-4. PubMed ID: 11904090
[No Abstract] [Full Text] [Related]
18. Two cases of visceral leishmaniasis in Colombia resistant to meglumine antimonial treatment.
Vélez ID; Colmenares LM; Muñoz CA
Rev Inst Med Trop Sao Paulo; 2009; 51(4):231-6. PubMed ID: 19739006
[TBL] [Abstract][Full Text] [Related]
19. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
[TBL] [Abstract][Full Text] [Related]
20. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis.
Disch J; Oliveira MC; Orsini M; Rabello A
Acta Trop; 2004; 92(3):279-83. PubMed ID: 15533299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
